Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

Thermo Fisher: new pumps compatible with all bioprocessing techs

16-Apr-2014 - Thermo Fisher has launched a pump technology designed for applications across the bioprocessing production line and usable with "all" bioprocessing tech.

Novartis eyes Asian market with $160m Singapore ophthalmic plant

15-Apr-2014 - Novartis subsidiary Alcon has opened the doors to its new $160m facility in Singapore for the manufacture of ophthalmic drugs.

UPDATE

Sun Pharma's $3.2bn Ranbaxy acq: 'Compliance first, synergies later'

07-Apr-2014 - Regulatory compliance will be the number one focus for Sun Pharma, the company says, following its $3.2bn (€2.3bn) takeover of Indian generics firm Ranbaxy.

Baxter gains access to haemophilia gene therapy platform in $70m Chatham buy

02-Apr-2014 - Baxter has announced plans to buy gene therapy developer Chatham Therapeutics for $70m in a deal focused on the latter’s pipeline of haemophilia candidates and gene therapy delivery platform.

GSK to invest $166m in manufacturing in Sub-Saharan Africa

31-Mar-2014 - GSK says it intends to build five new drug manufacturing as part of a £130m ($215m) investment in sub-Saharan Africa.

News in brief

Baxter to continue to grow manufacturing network in pharma spin-out

31-Mar-2014 - Baxter says it will spin out its pharma business to form two separate companies by 2015.

Hospira adds $60m to Rocky Mount's turnaround in lawsuit settlement

31-Mar-2014 - Hospira has agreed to pay $60m (€44m) to settle a lawsuit related to manufacturing and quality control deficiencies at its Rocky Mount facility, which is already subject to a $200m remediation programme.

Janssen Button? Will GSK's F1 team up prompt other collaborations?

26-Mar-2014 - GSK has ‘smashed’ production targets at a UK inhaler plant by revving up manufacturing operations with knowhow developed in Formula One pit lanes by partner, McLaren.

Interphex day 3

Live from Interphex 2014

19-Mar-2014 - .

DISPATCHES FROM INTERPHEX 2014

'Podular' manufacturing to become facility norm within 5 years, say GEA and G-CON

19-Mar-2014 - ‘Podular’ manufacturing systems will dominate facility design within five years, say G-CON and GEA who have teamed with Pfizer to create a flexible, repurposable and portable facility. 

Opportunities outweigh risks in China, says Eli Lilly

17-Mar-2014 - Eli Lilly says the opportunities in China outweigh any perceived challenges as it begins a $70m expansion of its manufacturing joint venture.

Sun down on latest Indian US FDA import alert

13-Mar-2014 - Sun Pharma’s antibiotic facility import alert is the latest blow to the Indian drug industry but is unlikely to impact revenues or cause US shortages, the firm says.

Gov set on enhancing UK supply chain competitiveness

12-Mar-2014 - The UK Government has set out to make Britain a more attractive place from which to source drugs and ingredients by awarding a series of taxpayer funded grants to supply chain focused innovation projects.

Pfizer invests in Indonesian solid dose facility

11-Mar-2014 - Pfizer’s $3.5m expansion of an Indonesian solid oral dose plant will increase capacity by 76%, the company says.

UK Gov backs GSK-led manufacturing project citing "British prowess"

06-Mar-2014 - A GSK-led consortium will develop manufacturing technologies in a Government-backed scheme intended to safeguard the UK drug production sector.

UPDATE

Boehringer commits $450m extra to fix empagliflozin plant after FDA criticism

06-Mar-2014 - Boehringer Ingelheim says it will pump a further €330m ($453m) into a German manufacturing facility critised by the US FDA in its rejection of the drug empagliflozin.

US FDA calls for annual reports of postapproval manufacturing changes

06-Mar-2014 - The US FDA has released draft guidance  on how post-approval manufacturing changes should be reported in annual reports.

Lilly looks local with Brazilian packaging investment

04-Mar-2014 - Eli Lilly says investment in its Sao Paolo, Brazil packaging plant will support growth for the local market.

EMA finalizes guidance on process validation for manufacturers

04-Mar-2014 - The European Medicines Agency (EMA) stressed the potential benefits of continuous process validation in guidance issued this week and underlined that data submitted by drugmakers must demonstrate the adequacy of production operations at each site.

Bayer looks to grow Chinese OTC business with Dihon acquisition

03-Mar-2014 - Bayer has predicted double digit growth in its Chinese consumer health business as it acquires OTC firm Dihon Pharmaceutical Group.

Novartis closing UK site, but will $1m per week R&D spend benefit CROs?

27-Feb-2014 - Novartis says it will continue to spend around $1m a week on clinical trials in the UK after its R&D site closes in June.

Middle income countries face obstacles in access to drugs despite making them, study finds

27-Feb-2014 - National prioritization, investments in healthcare infrastructure and building better epidemiological and cost databases could bring more innovative medicines to middle-income countries, according to an independent study  conducted by Charles River Associates. 

Pfizer thyroid drug back in production after packaging prob caused a stink

26-Feb-2014 - Pfizer says its hypothyroid drug Levoxyl will be available within a week after a musty smell coming from the oxygen-absorbing canister stopped production last February.

US FDA's 'super-office' to focus on all things quality, home and away

24-Feb-2014 - Development of a new quality "super office" was motivated by a desire to simplify oversight and is not a response to the recent spate of problems at overseas suppliers, says the US FDA.

PEOPLE ON THE MOVE

Boehringer Ingelheim biopharma head joins Merck, plus EMA, Shire, EFPIA

24-Feb-2014 - Simon Sturge leaves Boehringer Ingelheim to head Merck's biosimilars unit, as well as the European Medicines Agency, Shire and EFPIA in this week's People on the Move column.

Spotlight

EMA to rejig variations procedures and industry contact staff in April

EMA to rejig variations procedures and industry contact staff in April

Pharmaceutical firms working in Europe may need to update their address books next month after more reorganisation...

Janssen Button? Will GSK's F1 team up prompt other collaborations?

Janssen Button? Will GSK's F1 team up prompt other collaborations?

GSK has ‘smashed’ production targets at a UK inhaler plant by revving up manufacturing operations with knowhow...

Indian API maker slammed with US FDA Warning over data issues

Indian API maker slammed with US FDA Warning over data issues

Failure in maintaining test and production data has landed an Indian API maker with a Warning Letter...

US FDA issues new bioavailability guidelines

US FDA issues new bioavailability guidelines

The US FDA has published guidance of how sponsors should best document the bioavailability of products for...

Bioavailability breakthrough key to new cancer drug OKed in Japan

Bioavailability breakthrough key to new cancer drug OKed in Japan

Japan has become the first country to approve a new cancer pill that treats disease by interfering...

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing